Literature DB >> 6604362

Abattoir survey of bovine kidney disease.

M L Monaghan, J Hannan.   

Abstract

A survey of the prevalence and type of renal disease was carried out at a Dublin abattoir in 1979-80. Of 4166 cattle surveyed, 173 (4.2 per cent) had kidneys rejected for gross abnormalities. The rejection rate was 7.7, 1.7, 2.2 and 28 per cent for cows, bullocks, heifers and bulls, respectively. The most common reason for rejection was focal interstitial nephritis (60.1 per cent of rejected kidneys). Other lesions included cysts (26.0 per cent), pigmentation (6.4 per cent), pyelonephritis (3.5 per cent), amyloidosis (2.9 per cent), glomerulonephritis (0.6 per cent), renal atrophy (0.6 per cent) and agonal haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604362     DOI: 10.1136/vr.113.3.55

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

1.  Adverse effects of a 10-day course of ibuprofen in Holstein calves.

Authors:  P Walsh; F R Carvallo Chaigneau; M Anderson; N Behrens; H McEligot; B Gunnarson; L J Gershwin
Journal:  J Vet Pharmacol Ther       Date:  2016-02-14       Impact factor: 1.786

2.  A 30% incidence of renal cysts with varying sizes and densities in biomedical research swine is not associated with renal dysfunction.

Authors:  Belinda I Gómez; Joshua S Little; Alisa J Leon; Ian J Stewart; David M Burmeister
Journal:  Animal Model Exp Med       Date:  2020-09-10

3.  Bovine renal lipofuscinosis: prevalence, genetics and impact on milk production and weight at slaughter in Danish cattle.

Authors:  Jørgen S Agerholm; Knud Christensen; Søren Saxmose Nielsen; Pia Flagstad
Journal:  Acta Vet Scand       Date:  2009-02-12       Impact factor: 1.695

4.  Pathological findings of slaughtered camels' (Camelus dromedaris) kidneys in Najaf-Abad, Iran.

Authors:  Gholam Ali Kojouri; Hossein Nourani; Sirous Sadeghian; Hadi Imani; Abbas Raisi
Journal:  Vet Res Forum       Date:  2014       Impact factor: 1.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.